NCT00163995

Brief Summary

This study looks at the iontophoresis of urotensin II in chronic liver disease patients.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 13, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 14, 2005

Completed
Last Updated

July 26, 2007

Status Verified

September 1, 2005

First QC Date

September 13, 2005

Last Update Submit

July 25, 2007

Conditions

Liver DiseasesCirrhosis

Keywords

Chronic Liver Disease

Interventions

urotensin IIDRUG

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Cirrhosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alfred Hospital

Melbourne, Victoria, 3181, Australia

RECRUITING

MeSH Terms

Conditions

Liver DiseasesFibrosis

Interventions

urotensin II

Condition Hierarchy (Ancestors)

Digestive System DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • William W Kemp, MBBS, FRACP

    The Alfred

    PRINCIPAL INVESTIGATOR

Central Study Contacts

William W Kemp, MBBS, FRACP

CONTACT

92762000w.kemp@alfred.org.au

Study Design

Study Type
observational
Observational Model
DEFINED POPULATION
Time Perspective
OTHER
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

September 13, 2005

First Posted

September 14, 2005

Last Updated

July 26, 2007

Record last verified: 2005-09

Locations

AU(1)